Harvard Bioscience CFO Buys $25,000 of Stock as Company Outlines 2026 Plan
Harvard Bioscience Chief Financial Officer Mark T. Frost acquired 5,000 shares of the company's common stock on March 16, 2026, paying $5.00 per share for a $25,000 purchase. The transaction, disclosed in an April 1, 2026 SEC filing that accounts for a 10-for-1 reverse split on March 13, 2026, leaves Frost with 17,500 shares when including restrict…